FdaApplication
NDA 217766
Identifiers
- fda_app_no: NDA217766
Properties
| Property | Value |
|---|---|
| applicant_name | LONG GROVE PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2024-07-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | VASOPRESSIN | 40UNITS/100ML (0.4UNITS/ML) | SOLUTION;INTRAVENOUS |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | VASOPRESSIN | 20UNITS/100ML (0.2UNITS/ML) | SOLUTION;INTRAVENOUS |
| VASOPRESSIN IN SODIUM CHLORIDE 0.9% | VASOPRESSIN | 50UNITS/50ML (1UNIT/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
3 products